118 related articles for article (PubMed ID: 8971295)
1. A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients.
Lin DY; Sheen IS; Chu CM; Liaw YF
Aliment Pharmacol Ther; 1996 Dec; 10(6):961-6. PubMed ID: 8971295
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis.
Wang YJ; Lee SD; Hsieh MC; Lin HC; Lee FY; Tsay SH; Tsai YT; Hu OY; King ML; Lo KJ
J Hepatol; 1994 Nov; 21(5):872-7. PubMed ID: 7890905
[TBL] [Abstract][Full Text] [Related]
3. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.
Liaw YF; Tai DI; Chu CM; Chen TJ
Hepatology; 1988; 8(3):493-6. PubMed ID: 3371868
[TBL] [Abstract][Full Text] [Related]
4. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study.
Liaw YF; Lin DY; Chen TJ; Chu CM
Liver; 1989 Aug; 9(4):235-41. PubMed ID: 2770436
[TBL] [Abstract][Full Text] [Related]
5. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study.
Sheen IS; Liaw YF; Lin DY; Chu CM
J Hepatol; 1996 May; 24(5):525-31. PubMed ID: 8773906
[TBL] [Abstract][Full Text] [Related]
7. Colchicine in the treatment of cirrhosis of the liver.
Kershenobich D; Vargas F; Garcia-Tsao G; Perez Tamayo R; Gent M; Rojkind M
N Engl J Med; 1988 Jun; 318(26):1709-13. PubMed ID: 3287167
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].
Simon K; Gładysz A; Zalewska M; Machaj A
Przegl Epidemiol; 1991; 45(4):331-4. PubMed ID: 1841412
[TBL] [Abstract][Full Text] [Related]
9. Colchicine treatment of liver fibrosis.
Nikolaidis N; Kountouras J; Giouleme O; Tzarou V; Chatzizisi O; Patsiaoura K; Papageorgiou A; Leontsini M; Eugenidis N; Zamboulis C
Hepatogastroenterology; 2006; 53(68):281-5. PubMed ID: 16608040
[TBL] [Abstract][Full Text] [Related]
10. [Colchicine in the treatment of liver cirrhosis].
Quijano-Pitman F
Gac Med Mex; 1998; 134(5):610. PubMed ID: 9842143
[No Abstract] [Full Text] [Related]
11. Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin.
Kwon OC; Hong S; Ghang B; Kim YG; Lee CK; Yoo B
Am J Med; 2017 May; 130(5):583-587. PubMed ID: 28065770
[TBL] [Abstract][Full Text] [Related]
12. Colchicine reduces procollagen III and increases pseudocholinesterase in chronic liver disease.
Muntoni S; Rojkind M; Muntoni S
World J Gastroenterol; 2010 Jun; 16(23):2889-94. PubMed ID: 20556834
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells.
Xu L; Gong Y; Wang B; Shi K; Hou Y; Wang L; Lin Z; Han Y; Lu L; Chen D; Lin X; Zeng Q; Feng W; Chen Y
J Gastroenterol Hepatol; 2014 Aug; 29(8):1620-8. PubMed ID: 24942592
[TBL] [Abstract][Full Text] [Related]
14. Natural history of compensated viral B and D cirrhosis.
Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
[TBL] [Abstract][Full Text] [Related]
15. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
Mazzella G; Accogli E; Sottili S; Festi D; Orsini M; Salzetta A; Novelli V; Cipolla A; Fabbri C; Pezzoli A; Roda E
J Hepatol; 1996 Feb; 24(2):141-7. PubMed ID: 8907566
[TBL] [Abstract][Full Text] [Related]
16. Natural history and prognostic factors for chronic hepatitis type B.
Fattovich G; Brollo L; Giustina G; Noventa F; Pontisso P; Alberti A; Realdi G; Ruol A
Gut; 1991 Mar; 32(3):294-8. PubMed ID: 2013423
[TBL] [Abstract][Full Text] [Related]
17. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
Iloeje UH; Yang HI; Su J; Jen CL; You SL; Chen CJ;
Gastroenterology; 2006 Mar; 130(3):678-86. PubMed ID: 16530509
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial.
Cortez-Pinto H; Alexandrino P; Camilo ME; Gouveia-Oliveira A; Santos PM; Alves MM; Moura MC
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):377-81. PubMed ID: 11943949
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
20. [Post-hepatitis B, B-D and C cirrhosis].
Marcellin P
Rev Prat; 1991 May; 41(13):1149-55. PubMed ID: 1905835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
